PCA
AMGN icon

Purkiss Capital Advisors’s Amgen AMGN Stock Holding History

Purkiss Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Sell
898
-35
-4% -$12K 0.12% 134
2026
Q1 		$328K Buy
933
+185
+25% +$66K 0.14% 120
2025
Q4 		$245K Hold
748
– – 0.11% 148
2025
Q3 		$211K Hold
748
– – 0.1% 158
2025
Q2 		$209K Sell
748
-115
-13% -$32.6K 0.12% 142
2025
Q1 		$269K Buy
+863
New +$255K 0.2% 85

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Purkiss Capital Advisors's AMGN Position: Q2 2026 in Review

Purkiss Capital Advisors reduced its Amgen (AMGN) stake by 3.8% in Q2 2026, selling an estimated $12K and leaving 898 shares worth $325K. The position accounts for 0.12% of the portfolio, ranked #134.

Purkiss Capital Advisors first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $328K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Purkiss Capital Advisors held 898 shares of Amgen worth $325K as of Q2 2026.
  • Purkiss Capital Advisors sold 35 Amgen shares in Q2 2026, an estimated $12K.
  • Amgen made up 0.12% of Purkiss Capital Advisors's portfolio in Q2 2026, its #134 holding.
  • Purkiss Capital Advisors first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • Purkiss Capital Advisors's Amgen position peaked at $328K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Purkiss Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.